These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8976286)

  • 1. Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie's disease.
    Van de Water L
    J Urol; 1997 Jan; 157(1):306-10. PubMed ID: 8976286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix.
    Greiling D; Clark RA
    J Cell Sci; 1997 Apr; 110 ( Pt 7)():861-70. PubMed ID: 9133673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin deposition in Peyronie's disease plaque.
    Somers KD; Dawson DM
    J Urol; 1997 Jan; 157(1):311-5. PubMed ID: 8976287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of alphav/beta3 mRNA by fibrin1.
    Feng X; Clark RA; Galanakis D; Tonnesen MG
    J Invest Dermatol; 1999 Dec; 113(6):913-9. PubMed ID: 10594730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibronectin in normal wound healing.
    Lenselink EA
    Int Wound J; 2015 Jun; 12(3):313-6. PubMed ID: 23742140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The provisional matrix: setting the stage for tissue repair outcomes.
    Barker TH; Engler AJ
    Matrix Biol; 2017 Jul; 60-61():1-4. PubMed ID: 28527902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of growth factors and extracellular matrix in wound healing after laryngotracheal reconstruction.
    Walner DL; Heffelfinger SC; Stern Y; Abrams MJ; Miller MA; Cotton RT
    Otolaryngol Head Neck Surg; 2000 Mar; 122(3):363-6. PubMed ID: 10699811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen inhibits fibroblast-mediated contraction of collagen.
    Nien YD; Han YP; Tawil B; Chan LS; Tuan TL; Garner WL
    Wound Repair Regen; 2003; 11(5):380-5. PubMed ID: 12950643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
    Pierce GF; Tarpley JE; Yanagihara D; Mustoe TA; Fox GM; Thomason A
    Am J Pathol; 1992 Jun; 140(6):1375-88. PubMed ID: 1376557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fibronectin in fibroblast migration during tissue repair.
    Briggs SL
    J Wound Care; 2005 Jun; 14(6):284-7. PubMed ID: 15974416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization.
    Clark RA; Lanigan JM; DellaPelle P; Manseau E; Dvorak HF; Colvin RB
    J Invest Dermatol; 1982 Nov; 79(5):264-9. PubMed ID: 6752288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin in healing rabbit corneal wounds.
    Fujikawa LS; Foster CS; Harrist TJ; Lanigan JM; Colvin RB
    Lab Invest; 1981 Aug; 45(2):120-9. PubMed ID: 7022020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor expression in Peyronie's disease.
    Mulhall JP; Thom J; Lubrano T; Shankey TV
    J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.
    Brown LF; Yeo KT; Berse B; Yeo TK; Senger DR; Dvorak HF; van de Water L
    J Exp Med; 1992 Nov; 176(5):1375-9. PubMed ID: 1402682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D; Liu W; Ao Q; Wang G
    Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of traction therapy for Peyronie's disease: present and prospect].
    He ZH; Lu YP
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):78-82. PubMed ID: 24527543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scar contracture: cellular and connective tissue aspects in Peyronie's disease.
    Ehrlich HP
    J Urol; 1997 Jan; 157(1):316-9. PubMed ID: 8976288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie's disease?
    Gelbard M
    J Sex Med; 2008 Dec; 5(12):2974-6. PubMed ID: 19090949
    [No Abstract]   [Full Text] [Related]  

  • 20. Accelerated epithelization under a highly vapor-permeable wound dressing is associated with increased precipitation of fibrin(ogen) and fibronectin.
    Jonkman MF; Hoeksma EA; Nieuwenhuis P
    J Invest Dermatol; 1990 Apr; 94(4):477-84. PubMed ID: 2179419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.